Dr. Michael P. Defrain, MD

Dr. Defrain practices at AdventHealth Tampa in Tampa, Florida, part of AdventHealth.

Dr. Defrain's NPI, 1851369490, was assigned on March 9, 2006. Dr. Defrain graduated from Wayne State University School Of Medicine in 1998. Dr. Defrain holds Florida license ME104727.

Dr. Defrain's primary practice is AdventHealth Tampa, at 3100 E Fletcher Ave, Tampa, FL 33613 in Hillsborough County. The practice phone is (813) 615-7200.

Dr. Defrain's primary practice is AdventHealth Tampa in Tampa, Florida, part of AdventHealth. Dr. Defrain is also affiliated with Ascension Sacred Heart Pensacola. The medical group on file is AdventHealth Medical Group Cardiovascular Surgery at Tampa. Dmand AI also links Dr. Defrain to 4 more hospitals, 6 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Defrain practices, 11 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Defrain's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Defrain is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dmand AI has Dr. Defrain's licenses on file in 7 states: Florida, California, Texas, Michigan, Tennessee, Virginia and South Carolina.

Dmand AI lists heart bypass surgery, heart valve surgery and lung resection among the conditions Dr. Defrain treats.

CMS data shows 511 Medicare services from Dr. Defrain across 14 procedure codes in 2024, for 260 Medicare patients. Medicare paid $120,549 for them.

CMS counts 260 Medicare patients who saw Dr. Defrain in 2024. The largest group is 75 to 84, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Defrain's median patient age at 75, with 41% women.

In 2024, Dr. Defrain wrote 78 Medicare Part D claims for 37 patients. 96% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $31 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

Dr. Defrain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 23 procedures of coronary artery bypass graft (cabg) by Dr. Defrain, more than 73% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Defrain, published from 2022 to 2023. Dr. Defrain's most frequent co-authors are David J. Bailey, MD, Tanvir Khalid Bajwa, MD and Atul K. Chawla, MD.

Dmand AI links Dr. Defrain to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Atrial Fibrillation, Ventricular Outflow Obstruction and Aortic Valve Stenosis. Open Payments lists research payments to Dr. Defrain that name 1 trial.

CMS Open Payments shows 307 general payments to Dr. Defrain from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Lsi Solutions Inc paid the most, $103,494. It also lists 3 research payments totaling $1,185 in 2017, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Defrain.

Dr. Defrain graduated from Wayne State University School Of Medicine in 1998. Dr. Defrain is a member of ACS.

Dr. Defrain is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.